Multiple clinical reviews and trials confirm that cranial radiotherapy is a recognized risk factor leading to neurocognitive impairment, often referred to as cognitive decline or chemo brain effects in cancer survivors.
The provided papers consistently demonstrate that cranial radiotherapy causes neurocognitive decline, memory loss, and brain injury across both clinical and animal studies. There are no refuting studies present.